You are here: Industry Insights > 2019

News List

Bayer announces major restructure, 12,000 jobs to go pharmafile
December 03, 2018
Bayer has announced a major restructure of its operations in 2019 which will see the loss of 12,000 of its 118,200 positions following a number of lawsuits in the wake of its $63 billion buyout of agricultural biotech firm Monsanto.
MAGI partnering with PharmaTimes for the 2019 Clinical Researcher of the Year - The Americas pharmatimes
November 26, 2018
PharmaTimes are pleased to announce we will be partnering with MAGI to bring the Clinical Researcher of the Year competition to new audiences in the Americas.
MAGI partnering with PharmaTimes for the 2019 Clinical Researcher of the Year - The Americas pharmatimes
November 23, 2018
PharmaTimes are pleased to announce we will be partnering with MAGI to bring the Clinical Researcher of the Year competition to new audiences in the Americas.
Novo Nordisk cuts 1300 jobs in the midst of Trump's pricing pressures and depreciation of US dollar pharmafile
November 20, 2018
Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision has come partly in response to the Trump administration’s
Phamaceutical trade lobby responds to Brexit deal pharmafile
November 16, 2018
The Association of the British Pharmaceutical Industry (ABPI) has responded to Theresa May’s Brexit deal, after the government announced a 585 page draft withdrawal
AZ and MSD’s Lynparza shows significant results in ovarian cancer pharmatimes
November 01, 2018
AstraZeneca and MSD’s Lynparza improved progression-free survival by 70% compared to placebo in BRCA-mutated ovarian cancer patients who were in complete or partial response...
Diabetes causing 500 premature deaths a week pharmatimes
November 01, 2018
A new analysis by Diabetes UK has calculated that 500 people with diabetes die prematurely every week in England and Wales, with a significant number of these deaths down to avoidable complications.
Gilead Sciences: Investors Are Betting On A Better 2019 forbes
February 08, 2018
The hepatitis C virus. For years, U.S. drug maker Gilead Sciences has been hobbled by weakening sales of drugs for this liver-damaging viral infection.

Previous page 1 2 3 Next page